About Farsø Sygehus
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Farsø Sygehus
During the past decade, Farsø Sygehus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B
2009-04-01
2013-05-01
Completed
360
BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)
2010-04-19
2017-11-26
Completed
364
Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients
2010-06-01
2014-01-01
Completed
378
Epidemiological Study of Chronic Thromboembolic Pulmonary Hypertension in China
2012-10-01
2015-10-01
Unknown status
400
Optimal Antiplatelet Therapy for Chinese Patients With Coronary Artery Disease
2012-11-01
2015-03-01
Completed
14,032
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Farsø Sygehus"
#1 collaborator was "Bispebjerg Hospital" with 1 trials as a collaborator, "Farsø Sygehus" with 1 trials as a collaborator, "Gentofte Hospital" with 1 trials as a collaborator, "Hvidovre University Hospital" with 1 trials as a collaborator and "Regionshospitalet Viborg, Skive" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 6 trials.
Clinical Trials Conditions at Farsø Sygehus
According to Clinical.Site data, the most researched conditions in "Farsø Sygehus" are
"Anemia" (1 trials), "Arthroplasty, Replacement, Hip" (1 trials), "Arthroplasty, Replacement, Knee" (1 trials) and "Osteoarthritis Susceptibility 3" (1 trials). Many other conditions were trialed in "Farsø Sygehus" in a lesser frequency.
Clinical Trials Intervention Types at Farsø Sygehus
Most popular intervention types in "Farsø Sygehus" are "Drug" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Iron-III Isomaltoside 1000" (1 trials), "Standard Care" (1 trials) and "assessment of motorfunction in PACU" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Farsø Sygehus
The vast majority of trials in "Farsø Sygehus" are
2 trials for "All" genders.
Clinical Trials Status at Farsø Sygehus
Currently, there are NaN active trials in "Farsø Sygehus".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Farsø Sygehus,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Farsø Sygehus, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".